How might corneal elasticity help us understand diabetes and intraocular pressure?

Journal of Refractive Surgery

Volumn 23, Issue 1, 2007, Pages 85-88

  Krueger, Ronald R ^a   Ramos Esteban, Jerome C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

CORRELATION ANALYSIS; CROSS LINKING; DIABETES MELLITUS; DISEASE COURSE; ELASTICITY; GLAUCOMA; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KERATOCONUS; KERATOMETRY; OPEN ANGLE GLAUCOMA; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RIGIDITY; SELF REPORT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EID: 33846266195     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081-597x-20070101-13     Document Type: Review

References (38)

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627.
2. Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg. 1999;15:711-713.
3. Sady C, Khosrof S, Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun. 1995;214:793-797.
4. Seiler T, Huhle S, Spoerl E, Kunath H. Manifest diabetes and keratoconus: a retrospective case-control study. Graefes Arch Clin Exp Ophthalmol. 2000;238:822-825.
5. Kuo IC, Broman A, Pirouzmanesh A, Melia M. Is there an association between diabetes and keratoconus? Ophthalmology. 2006;113:184-190.
6. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108:1779-1788.
7. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408.
8. Ehlers N. On corneal thickness and intraocular pressure. II. A clinical study on the thickness of the corneal stroma in glaucomatous eyes. Acta Ophthalmol (Copenh). 1970;48:1107-1112.
9. Emara BY, Tingey DP, Probst LE, Motolko MA. Central corneal thickness in low-tension glaucoma. Can J Ophthalmol. 1999;34:319-324.
10. Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137-1141.
11. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
12. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
13. Katz J, Sommer A. Risk factors for primary open angle glaucoma. Am J Prev Med. 1988;4:110-114.
14. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101:1173-1177.
15. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104:712-718.
16. Chopra V, Doshi V, Francis BA, Azen S, Varma R. Diabetes mellitus, hypertension and the prevalence of open-angle glaucoma in the adult Latinos: The Los Angeles Latino Eye Study (LALES). Invest Ophthalmol Vis Sci. 2006;ARVO abstract #3433:163.
17. Uhm KB, Shin DH. Glaucoma risk factors in primary open-angle glaucoma patients compared to ocular hypertensives and control subjects. Korean J Ophthalmol. 1992;6:91-99.
18. Dielemans I, de Jong PT, Stolk R, Vingerling JR, Grobbee DE, Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology. 1996;103:1271-1275.
19. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102:48-53.
20. Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye. 1994;8:315-320.
21. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113:918-924.
22. Weih LM, Nanjah M, McCarty CA, Taylor HR. Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology. 2001;108:1966-1972.
23. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119:1819-1826.
24. Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol. 1994;1:131-138.
25. Kaimbo DK, Buntinx F, Missotten L. Risk factors for open-angle glaucoma: a case-control study. J Clin Epidemiol. 2001;54:166-171.
26. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066-1071.
27. Georgopoulos G, Andreanos D, Liokis N, Papakonstantinou D, Vergados J, Theodossiadis G. Risk factors in ocular hypertension. Eur J Ophthalmol. 1997;7:357-363.
28. Wolfs RC, Burger PH, Ramrattan RS, Klaver CC, Hulsman CA, Hofman A, Vingerling JR, Hitchings RA, de Jong PT. Changing views on open-angle glaucoma: definitions and prevalences-The Rotterdam Study. Invest Ophthalmol Vis Sci. 2000;41:3309-3321.
29. de Voogd S, Ikram MK, Wolfs RC, Jansonius NM, Witteman JCM, Hofman A, de Jong PT. Is diabetes mellitus a risk factor for open-angle glaucoma? Ophthalmology. 2006;113:1827-1831.
30. Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg. 2005;31:156-162.
31. Congdon NG, Broman AT, Bandeen-Roche K, Grover D, Quigley HA. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol. 2006;141:868-875.
32. Dupps WJ Jr, Netto MV, Herekar S, Krueger RR. Surface wave elastometry of the cornea in porcine and human donor eyes. J Refract Surg. 2007;23:66-75.
33. Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg. 2006;32:837-845.
34. Hennis A, Wu SY, Nemesure B, Leske MC; Barbados Eye Studies Group. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology. 2003;110:908-914.
35. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224-2228.
36. Wu SY, Nemesure B, Hennis A, Leske MC. Nine-year changes in intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol. 2006;124:1631-1636.
37. Oh SW, Lee S, Park C, Kim DJ. Elevated Intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev. 2005;21:434-440.
38. Medeiros FA, Weinreb RN, Sample PA, Gomi CF, Bowd C, Crowston JG, Zanguill LM. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005;123:1351-1360.